The fusion type of NTRK2 is specifically decreased in breast cancer [21] while NTRK2 itself is closely related to breast cancer; it is related to sleep disorders after surgery and increases the incidence of side effects after chemotherapy [22]. Here, NTRK2 is linked to breast carcinoma.